Provided by Tiger Trade Technology Pte. Ltd.

SELLAS Life Sciences Group Inc.

4.50
+0.35008.43%
Post-market: 4.540.0411+0.91%16:52 EST
Volume:11.30M
Turnover:51.85M
Market Cap:765.00M
PE:-16.00
High:4.82
Open:4.26
Low:4.25
Close:4.15
52wk High:5.18
52wk Low:0.9516
Shares:170.00M
Float Shares:170.00M
Volume Ratio:2.42
T/O Rate:6.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2813
EPS(LYR):-0.5046
ROE:-84.33%
ROA:-44.90%
PB:16.77
PE(LYR):-8.92

Loading ...

New NASA Chief Vows: Moon Return Within Trump's Term

Stock News
·
Dec 28, 2025

Key Reasons Behind Jared Isaacman's Appointment as NASA Administrator and Analysis of the Athena Plan

Deep News
·
Dec 21, 2025

SELLAS Life Sciences Group (SLS): Valuation Check After Positive Phase 2 Data for SLS009 in AML

Simply Wall St.
·
Dec 10, 2025

Sellas Life Says Phase 2 Study of Cancer Combination Treatment Shows 'Clinically Meaningful' Activity; Shares Up Pre-Bell

MT Newswires Live
·
Dec 08, 2025

Sellas Life Sciences Announces Positive Phase 2 Results for SLS009 Combination in Relapsed AML

Reuters
·
Dec 08, 2025

SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025

GlobeNewswire
·
Dec 08, 2025

Director Katherine Bach Kalin Acquires Common Shares of Sellas Life Sciences Group Inc

Reuters
·
Nov 21, 2025

SELLAS Life Sciences Q3 Net Income USD -6.791 Million

Reuters
·
Nov 20, 2025

SELLAS Life Sciences Q3 net loss narrows to $6.8 mln

Reuters
·
Nov 13, 2025

BRIEF-SELLAS Life Sciences Q3 Net Income USD -6.791 Million

Reuters
·
Nov 13, 2025

Press Release: SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Nov 13, 2025

Sellas Life Sciences options imply 12.3% move in share price post-earnings

TIPRANKS
·
Nov 13, 2025

Papa John's Is Not First: Here Are 3 Other Stocks Rocked By Market-Moving Fake News

Benzinga_recent_news
·
Nov 11, 2025

Sellas Life Sciences Group Inc expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

Ero Announces Result of Year-Long Value-Creation Initiative at Xavantina, Commences First Gold Concentrate Sales in Q4 2025

GlobeNewswire
·
Nov 04, 2025

Sellas Life Sciences Unveils Phase 2 Data for SLS009 Combo in Relapsed AML at ASH 2025

Reuters
·
Nov 03, 2025

Sellas Life Sciences Raises $31 Million From Exercise of Warrants

MT Newswires Live
·
Oct 27, 2025

BRIEF-SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds

Reuters
·
Oct 27, 2025

SELLAS Life Sciences to Participate in the J.P. Morgan U.S. Opportunities Forum

GlobeNewswire
·
Oct 22, 2025

Evonik Partners with Schneider Electric: New Products Reduce Carbon Emissions by 70% and Enable 3D Printing Applications

Deep News
·
Oct 14, 2025